Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-25-331299

VP, Finance and Controller sold 389 shares at $8.68 ($3,377)

  • VP, Finance and Controller acquired 1,086 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gupta Ashoo · VP, Finance and Controller

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-20 Exercise or conversion : show line 1 in the form +866 46,528 D
2025-12-20 Sale : show line 2 in the form −310 $8.68 $2,691 46,218 D
2025-12-20 Exercise or conversion : show line 3 in the form +220 46,438 D
2025-12-20 Sale : show line 4 in the form −79 $8.68 $686 46,359 D
Open-market sales · 389 sh · avg $8.68 · $3,377

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-12-20 Exercise or conversion : show line 5 in the form Restricted Stock Units −866 12,984 D
2025-12-20 Exercise or conversion : show line 6 in the form Restricted Stock Units −220 3,308 D
Loading xslF345X05/ownership.xml…